Another Cannabis Company Benefits From Maryland's Green Rush, iAnthus Cuts Q3 Net Loss While Growing Revenue

Author: Jelena Martinovic | November 10, 2023 10:19am

iAnthus Capital Holdings, Inc. (CSE:IAN) (OTCQB:ITHUF) reported its financial results on Thursday for the third quarter ended September 30, 2023.

Q3 2023 Financial Highlights

Revenue totaled $42.9 million, representing a quarter-over-quarter increase of 10.8% and an increase of 8.9% from the same quarter in the prior year.
Gross profit was $17.4 million, a sequential decrease of 5.2% and an increase of 7.7% from the same quarter in the prior year.
Gross margin was 40.6%, reflecting a sequential decrease of 687bps and a decrease of 47bps from the same quarter in the prior year.
Net loss amounted to $15.6 million, compared to a net loss of $20.1 million in the previous quarter, compared to a net loss of $22 million in the same quarter of 2022.
Adjusted EBITDA came in positive at $4.9 million, representing a sequential increase from an Adjusted EBITDA gain of $3.9 and an increase from a negative adjusted EBITDA of $0.3 million from the same quarter in the prior year.

Analyst Pablo Zuanic at research firm Z&A said in a recent report that iAnthus Capital and other top cannabis multi-state operators (MSOs) have benefitted from the launch of Maryland's recreational cannabis sales this summer.

Maryland experienced a significant increase in total sales, reaching $270 million for 3Q23, primarily due to the start of recreational sales in July.

“MSOs with exposure to Maryland will benefit, with varying effects based on their sales in the state. Ascend, Curaleaf, Green Thumb, TerrAscend, and Verano have four stores in Maryland; Columbia Care, iAnthus, and Trulieve each have three; most also engage in wholesale,” Zuanic wrote.

“Many firms don't break down sales by state, but Maryland will significantly impact Ascend, TerrAscend, iAnthus, and MariMed. Other MSOs have more diversified state portfolios, but Maryland remains a positive driver.”

In October, Maryland’s licensed retailers sold $90 million worth of medical and recreational cannabis products. Out of that sum, medical marijuana sales accounted for $35 million, while recreational sales amounted to $55 million, reaching a new record in the prior month.

ITHUF Price Action

iAnthus’ shares traded 1.7778% higher at $0.0229 per share at the market close on Thursday afternoon.

Related News

Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:

47.10% with $GTBIF

40.23% with $TCNNF

21.50% with $VFF

But here’s the kicker: Michael is about to release his next potential winners, and he’s chomping at the bit to share these ticker symbols with you ASAP.Don’t miss out on the green rush!

Photo: Courtesy of Elsa Olofsson on Unsplash

Posted In: CSE:IAN ITHUF